ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2021
Evaluating the impact of coronavirus disease 2019 on asthma morbidity: A comprehensive analysis of potential influencing factors.
Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pediatric asthma control during the COVID-19 pandemic: A systematic review and meta-analysis.Pediatric pulmonology · 2022Pooled it
- Knowledge Mapping of COVID-19 and Asthma/Allergic Rhinitis: A Visual and Bibliometric Analysis.Journal of asthma and allergy · 2025Article
- Changes in asthma emergency department visits in the United States during the COVID-19 pandemic.The Journal of asthma : official journal of the Association for the Care of Asthma · 2023Article
- Impact of the COVID-19 on asthma control among children: A systematic review.Journal of public health research · 2023Review
- Healthcare utilization in Canadian children and young adults with asthma during the COVID-19 pandemic.PloS one · 2023Article
- Management of patients with allergic diseases in the era of COVID-19.Clinical and experimental pediatrics · 2022Article
- Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022Article
- The effects of COVID-19 outbreak on pediatric emergency department admissions for acute wheezing.Pediatric pulmonology · 2022Article
- Understanding the environmental factors related to the decrease in Pediatric Emergency Department referrals for acute asthma during the SARS-CoV-2 pandemic.Pediatric pulmonology · 2022Article
- Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study.Journal of asthma and allergy · 2022Article
- Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic.Children (Basel, Switzerland) · 2021Article
- Changes in Tobacco Use Patterns among Veterans in San Diego during the Recent Peak of the COVID-19 Pandemic.International journal of environmental research and public health · 2021Article
- Reduced pediatric urgent asthma utilization and exacerbations during the COVID-19 pandemic.Pediatric pulmonology · 2021Article
- Journal Club: The Intersection of Racial/Ethnic Disparities in Coronavirus Disease 2019 and COPD.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2021Article
- Emergency Department Visits for allergy related-disorders among children: experience of a single Italian hospital during the first wave of the COVID-19 pandemic.Multidisciplinary respiratory medicine · 2021Article
- COVID-19-Related Pneumonia in an Adolescent Patient with Allergic Asthma.Case reports in medicine · 2021Article
- [Referral Criteria in Asthma: A Need Reinforced by the Pandemic].Open respiratory archivesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe coronavirus disease 2019 (COVID-19) pandemic period is experiencing better asthma control, fewer exacerbations, and health care utilization, with limited data on factors that could explain this phenomenon.
objectiveTo confirm these improved asthma outcomes during COVID-19 and evaluate potential contributing factors.
methodsIn 18,912 pediatric patients with asthma treated in the Children's Hospital of Orange County network from 2017 to 2020, monthly asthma-related encounters and medication summaries were extracted from electronic health records, particulate matter 2.5 (PM
resultsDuring COVID-19, we found 78%, 90%, 68% reductions in hospitalization, emergency department visits, and exacerbations, respectively, compared with pre-COVID-19 2020, with significantly greater changes than the same time period of 2017 to 2019 and significant reductions in albuterol and inhaled corticosteroid use (P < .05). Emergency department visit reduction was not seen for African Americans. The PM
conclusionOur data confirm reduced health care utilization and suggest better asthma control during COVID-19, except for African Americans. This was associated with a significant increase in telehealth visits and reductions in PM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.